Scaling Innovation: How DiscGenics and InVitria are Leading the Future of Cell Therapy

Reading time: 5 minutes Share this article:       The cell therapy industry stands on the edge of a transformative era. With advancements in treatment options and scalable manufacturing processes, companies like DiscGenics™ are leading the charge, delivering innovative therapies for previously intractable conditions. Simultaneously, market dynamics are shifting, with renewed investor confidence signaling …

Maintaining Viable Cell Count in Primary T Cells During Cell Washing Using Optibumin®

Key Points Optibumin®, InVitria’s high-purity recombinant human albumin, performs comparably to serum-derived albumin in cell wash experiments, retaining nearly all cells and maintaining excellent viability after washing. Optibumin offers the additional benefits of animal-free origin and consistent quality. Introduction Downstream cell washing is a critical step in cell therapy manufacturing processes (Figure 1). During this …